TTN p.Ile29773Leu

Variant summary

Our verdict is Likely benign.
-5 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -5 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_StrongB3_Supporting

The NM_001267550.2(TTN):c.89317A>T (p.Ile29773Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene TTN is a known oncogene (CancerMine: 4 oncogene, 1 driver citations). The gene TTN is a cancer driver gene (CancerMine: 4 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.00189 (AC=3,049) in the gnomAD database across 1,613,872 control chromosomes, including 47 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.0334. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.010 ( 20 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 27 hom. )

Consequence

TTN
NM_001267550.2 missense

Scores

1
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:26

Conservation

PhyloP100: 2.71

Publications

6 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1G
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • myopathy, myofibrillar, 9, with early respiratory failure
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
  • early-onset myopathy with fatal cardiomyopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • TTN-related myopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • tibial muscular dystrophy
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2J
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • TTN-related myopathy, dominant-negative TTNsv
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, G2P
  • congenital myopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • familial hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • hereditary skeletal muscle disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypertrophic cardiomyopathy 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001267550.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -5 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.0334 — exceeds 1% threshold (B1 applied)
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001267550.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TTN NM_001267550.2
MANE Select
HGVSc / HGVSpc.89317A>Tp.Ile29773Leu
Exon rankExon 334 of 363
missense
Prot: NP_001254479.2UniProt: Q8WZ42-12
TTN NM_001256850.1
HGVSc / HGVSpc.84394A>Tp.Ile28132Leu
Exon rankExon 284 of 313
missense
Prot: NP_001243779.1UniProt: Q8WZ42-1
TTN NM_133378.4
HGVSc / HGVSpc.81613A>Tp.Ile27205Leu
Exon rankExon 283 of 312
missense
Prot: NP_596869.4UniProt: Q8WZ42-11

Ensembl Transcripts

TTN ENST00000589042.5
TSL:5MANE Select
HGVSc / HGVSpc.89317A>Tp.Ile29773Leu
Exon rankExon 334 of 363
missense
Prot: ENSP00000467141.1UniProt: Q8WZ42-12
TTN ENST00000446966.2
TSL:1
HGVSc / HGVSpc.89161A>Tp.Ile29721Leu
Exon rankExon 332 of 361
missense
Prot: ENSP00000408004.2UniProt: A0A1B0GXE3
TTN ENST00000436599.2
TSL:1
HGVSc / HGVSpc.89041A>Tp.Ile29681Leu
Exon rankExon 332 of 361
missense
Prot: ENSP00000405517.2UniProt: A0A0C4DG59

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.0101
AC:1538
Hom:21
AN:152186
Cov:33
GnomAD2 exomes
AF: 0.00253
AC:629
AN:248516
GnomAD4 exome
AF: 0.00103
AC:1512
Hom:27
AN:1461568
Cov:33
GnomAD4 genome
AF: 0.0101
AC:1537
Hom:20
AN:152304
Cov:33
TOPMed (Bravo)
AF: 0.0119
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00216
AC:252
Hom:5
AN:116576
Local & regional cohorts 6 sources
ABraOM SABE-WGS-1171
AF: 0.00769
AC:18
Hom:0
AN:2342
ESP6500 (Exome Variant Server)
AF: 0.0104
AC:129
AN:12372
GenomeAsia100K
AF: 0.00173
AC:6
AN:3478
Qatari Genome
AF: 0.0170
AC:3
AN:176
Turkish Variome
AF: 0.000177
AC:1
Hom:0
AN:5174
UK10K
AF: 0.000132
AC:1
AN:7562
Showing 12 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.000104 *19622 0.00 *010426
BipEx
(Bipolar disorder (including schizoaffective))
0.0000352 128418 0.000104 328828
Epi25
(Epilepsy)
0.00307 12941956 0.00344 23066876
SCHEMA
(Schizophrenia)
0.00949 1158121994 0.0104 1983191254
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
10
not specified (10)
-
-
4
not provided (4)
-
-
2
Autosomal recessive limb-girdle muscular dystrophy type 2J (2)
-
-
2
Early-onset myopathy with fatal cardiomyopathy (2)
-
-
2
Myopathy, myofibrillar, 9, with early respiratory failure (2)
-
-
2
Tibial muscular dystrophy (2)
-
-
1
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G (1)
-
-
1
Cardiomyopathy (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Dilated cardiomyopathy 1G (1)

Computational Scores

AlphaGenome AVI
Uncertain19
AlphaMissense
Benign0.077
BayesDel_addAF
Benign-0.44T
BayesDel_noAF
Benign-0.39
CADD
Benign17
DANN
Benign0.69
Eigen
Benign-0.25
Eigen_PC
Benign-0.057
FATHMM_MKL
Uncertain0.88D
FuncVEP CTI
Benign0.00049
GPN-Star LLR
N/A-3.9
GPN-Star score
N/A3.9
LIST_S2
Benign0.63T
MetaRNN
Benign0.0049T
MetaSVM
Benign-1.1T
Mutation Taster
N/A91/9polymorphism
MutationAssessor
Benign0.32N
PhyloP100
Benign2.7
PrimateAI
Benign0.42T
PROVEAN
Benign0.39N
REVEL
Benign0.076
Sift
Benign0.71T
VESM-3B
Benign-3.6
Showing 23 of 23 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs77853750;
hg19: chr2-179418415;
COSMIC: COSV115018788;
COSMIC: COSV115018788;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.